SCHEMBL26549002

SCHEMBL26549002

C[Si](C)(C)c1ccc(-c2ccc(-c3ccc4ccc(-c5ccc(-c6ccc(F)cc6)cc5)cc4c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.46
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
NR3C1 P04150 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
HTT P42858 1/20 0.36
SCN5A Q14524 1/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2A6 P11509 1/20 0.34
LPL P06858 1/20 0.34
LIPG Q9Y5X9 1/20 0.34
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548657 1.00 PGR (0.46) PGRESR1ESR2PDGFRBPDGFRA
SCHEMBL26548672 1.00 PGR (0.46) PGRESR1ESR2PDGFRBPDGFRA
SCHEMBL26548134 0.94 PGR (0.47) PGRESR1ESR2PDGFRBPDGFRA
SCHEMBL26548156 0.94 PGR (0.47) PGRESR1ESR2PDGFRBPDGFRA
SCHEMBL26548515 0.94 PGR (0.47) PGRESR1ESR2PDGFRBPDGFRA
SCHEMBL26548674 0.90 ESR1 (0.46) ESR1ESR2SMN1; SMN2CA9SCN5A
SCHEMBL26549019 0.90 ESR1 (0.46) ESR1ESR2SMN1; SMN2CA9SCN5A
SCHEMBL26548544 0.83 ESR1 (0.44) ESR1ESR2SMN1; SMN2SCN5ACYP1A2
SCHEMBL26548158 0.83 ESR1 (0.44) ESR1ESR2SMN1; SMN2SCN5ACYP1A2
SCHEMBL26548994 0.83 PGR (0.53) PGRESR1ESR2PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PGR 4012/4885ESR1 940/4885ESR2 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.